EUVIMEDEUVIMED entdecken
Crossref

Rational Design and Synthesis of Isatin‐Chalcone Hybrids Integrated with 1 H ‐1,2,3‐Triazole: Anti‐Proliferative Profiling and Molecular Docking Insights

Swati, Asif Raza, Shefali Chowdhary, Amit Anand, Shaveta, Arun K Sharma, Kewal Kumar, Vipan Kumar iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Swati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Maharaja Ranjit Singh Punjab Technical University, Dabwali Road, Bathinda, India. Hauptthemen laut MEDLINE: Triazoles, Molecular Docking Simulation, Isatin, Drug Design. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: UGC (NFSC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, a series of isatin‐chalcone linked triazoles were synthesized using Cu‐promoted Azide‐Alkyne Cycloaddition (CuAAC) reaction and evaluated for their cytotoxicity against various cancer cell lines. The most potent compound displayed approximately 2.5 times greater activity compared to both reference compounds against ovarian cancer cell lines. These findings were supported by caspase‐mediated apoptosis and molecular docking analyses. Docking revealed comparable VEGFR‐2 affinities for 5 b and 5‐FU but highlighted stronger interaction of 5 b with EGFR, evident from its lower docking score. Overall, these results signify the notable anti‐proliferative potential of most synthesized hybrids, notably emphasizing the efficacy of compound 5 b in suppressing cancer cell growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesMolecular Docking SimulationIsatinDrug DesignCell ProliferationAntineoplastic AgentsDrug Screening Assays, AntitumorHumansStructure-Activity RelationshipCell Line, TumorChalconeMolecular StructureApoptosisDose-Response Relationship, DrugChalconesVascular Endothelial Growth Factor Receptor-2

Stichwörter der Autor:innen

Isatinchalconecytotoxic evaluationdockingtriazole

Substanzen

TriazolesIsatinAntineoplastic AgentsChalconeChalconesVascular Endothelial Growth Factor Receptor-2

Autor:innen und Institutionen

  • Department of Chemistry, Maharaja Ranjit Singh Punjab Technical University, Dabwali Road, Bathinda, India.
  • Department of Pharmacology, Penn State Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
  • Department of Chemistry, Guru Nanak Dev University, Amritsar, India.
  • Department of Chemistry, Khalsa College, Amritsar, India.
  • Department of Chemistry, Baba Farid College, Muktsar Road, Bathinda, India.

ORCID-Profile: Vipan Kumar

Förderung

  • UGC (NFSC)

Zitieren

APA

Swati, Raza, A., Chowdhary, S., Anand, A., Shaveta, Sharma, A. K., Kumar, K., & Kumar, V. (2024). Rational Design and Synthesis of Isatin‐Chalcone Hybrids Integrated with 1 H ‐1,2,3‐Triazole: Anti‐Proliferative Profiling and Molecular Docking Insights. ChemMedChem. https://doi.org/10.1002/cmdc.202400015

Vancouver

Swati, Raza A, Chowdhary S, Anand A, Shaveta, Sharma AK, et al. Rational Design and Synthesis of Isatin‐Chalcone Hybrids Integrated with 1 H ‐1,2,3‐Triazole: Anti‐Proliferative Profiling and Molecular Docking Insights. ChemMedChem. 2024. doi:10.1002/cmdc.202400015

BibTeX
@article{Swati2024,
  author = {Swati and Raza, Asif and Chowdhary, Shefali and Anand, Amit and Shaveta and Sharma, Arun K and Kumar, Kewal and Kumar, Vipan},
  title = {Rational Design and Synthesis of Isatin‐Chalcone Hybrids Integrated with 1 H ‐1,2,3‐Triazole: Anti‐Proliferative Profiling and Molecular Docking Insights},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400015}
}
Kostenlos starten →